- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 11/00 - Depsipeptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 11/00
Total number of patents in this class: 125
10-year publication summary
|
6
|
7
|
10
|
11
|
10
|
6
|
3
|
10
|
5
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Onkure, Inc. | 30 |
6 |
| The Regents of the University of California | 20902 |
4 |
| Massachusetts Institute of Technology | 10305 |
4 |
| Sanofi | 4326 |
4 |
| Novartis AG | 10169 |
3 |
| President and Fellows of Harvard College | 6115 |
3 |
| Bayer Cropscience LP | 262 |
2 |
| Board of Regents, The University of Texas System | 6172 |
2 |
| Agency for Science, Technology and Research | 3765 |
2 |
| University of Florida Research Foundation, Inc. | 4207 |
2 |
| The Broad Institute, Inc. | 1990 |
2 |
| Chugai Seiyaku Kabushiki Kaisha | 1426 |
2 |
| Karus Therapeutics Limited | 27 |
2 |
| Nanyang Technological University | 2239 |
2 |
| Osaka Prefecture University Public Corporation | 229 |
2 |
| The Regents of the University of Colorado, a body corporate | 2846 |
2 |
| Shenzhen Institutes of Advanced Technology | 1532 |
2 |
| Stella Pharma Corporation | 40 |
2 |
| University of Vermont and State Agricultural College | 402 |
2 |
| The USA, as represented by the Secretary, Dept. of Health and Human Services | 87 |
2 |
| Other owners | 73 |